Back to News
Market Impact: 0.2
BioStem Technologies Expands Hospital Access For VENDAJE And VENDAJE AC Through Vizient And Premier
Source: Nasdaq
Company FundamentalsProduct LaunchesCorporate Guidance & Outlook
BioStem Technologies said its VENDAJE and VENDAJE AC products were added to its existing supply contracts with Vizient and Premier. The update is a positive commercial traction signal for its perinatal tissue allograft franchise, but no financial terms or guidance changes were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
BSEM0.35
More News
- Indonesian stocks plunge to six-year low as MSCI downgrade fears mount
- China's CXMT sees shares drop over 6% as investors look past chipmaker's profit turnaround
- Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge
- India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance
- Zoom and big financial firms add ‘Proof of Human’ badges from Sam Altman’s World to stop fraud and deep fakes
- Daiichi Life Offers to Buy Remainder of Australia’s Challenger